Cardiology
RSSArticles
-
Clinical Briefs
In this section: the evolution of prostate cancer screening; the limitations of online health information; and treating polycystic ovary syndrome patients.
-
Valbenazine Capsules (Ingrezza)
Valbenazine is indicated for the treatment of tardive dyskinesia in adults.
-
Insomnia Disorder: Evidence for Psychological and Behavioral Interventions
Cognitive behavioral therapy for insomnia is an effective intervention for moderate to severe insomnia disorder and should be considered as an initial treatment.
-
Putting the Genie Back in the Prescription Bottle
Researchers recently developed an evidence-based algorithm for reducing the use of proton pump inhibitors.
-
Cognitive Behavioral Therapy for Chronic Low Back Pain
Low back pain and functional limitation scores in adults with chronic low back pain improved among those randomly assigned to receive either cognitive behavioral therapy or mindfulness-based stress reduction interventions when compared to usual care.
-
Alzheimer’s Prevention: No Harm in ‘Forgetting’ Vitamin E and/or Selenium
This large-scale study of asymptomatic elderly men reveals no indication that selenium or vitamin E (taken alone or in combination) prevents development of dementia.
-
Bergamot Shows Potential as an Alternative to Statins for Hyperlipidemia
Although larger controlled studies are warranted, bergamot supplementation may be an alternative approach to improving cardiovascular risk in patients who are unable or unwilling to take pharmaceutical HMG-CoA reductase or PCSK9 inhibitors.
-
Chondroitin Is as Effective as Celecoxib for Knee Arthritis
Six months of 800 milligrams of pharmaceutical-grade chondroitin sulfate daily relieved knee pain as much as 400 milligrams of celecoxib.
-
Left Ventricular Volume Affects Function in Chemotherapy Patients
Reductions in left ventricular ejection fraction in patients receiving potentially cardiotoxic chemotherapy may be because of significant decreases in left ventricular volume in up to 20% of these patients.
-
B-type Natriuretic Peptide Is Less Useful in Elderly Patients With Dyspnea
Among patients ≥ 80 years of age presenting with acute dyspnea, B-type natriuretic peptide level was not useful for differentiating cardiac vs. respiratory etiologies when added to a model of clinical predictors.